ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Haemato AG

Haemato AG (0VZ7)

5,92
0,00
( 0,00% )
Aktualisiert: 02:00:00

Haemato AG (0VZ7) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
5,92
( - )
Gebot
5,92
Fragen
5,92
Volumen
0,00
0,00 Tagesbereich 0,00
5,92 52-Wochen-Bereich 5,92
Marktkapitalisierung
Handelsende
5,92
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
929 €
Ausgegebene Aktien
5.227.588
Dividendenrendite (LTM)
1,2 (0,47%)
Kurs-Gewinn-Verhältnis
6,93
Gewinn pro Aktie (EPS)
1,88
Erlöse (LTM)
260,81M
Nettogewinn (LTM)
9,61M

Über Haemato AG

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cos... HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany. HAEMATO AG operates as a subsidiary of M1 Kliniken AG. Mehr anzeigen

Sektor
-
Branche
-
Website
Hauptsitz
Schönefeld, Germany
Gegründet
1993
Haemato AG is listed in the sector of the Londoner Börse with ticker 0VZ7. The last closing price for Haemato was 5,92 €. Over the last year, Haemato shares have traded in a share price range of 5,92 € to 5,92 €.

Haemato currently has 5.227.588 shares in issue. The market capitalisation of Haemato is 30,95 € million. Haemato has a price to earnings ratio (PE ratio) of 6.93.

0VZ7 Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
26005.925.925.9200DE
52005.925.925.9200DE
156005.925.925.92125.92DE
260005.925.925.9275.92DE

0VZ7 - Frequently Asked Questions (FAQ)

What is the current Haemato AG share price?
The current share price of Haemato AG is 5,92 €
How many Haemato AG shares are in issue?
Haemato AG has 5.227.588 shares in issue
What is the market cap of Haemato AG?
The market capitalisation of Haemato AG is EUR 30,95M
What is the 1 year trading range for Haemato AG share price?
Haemato AG has traded in the range of 5,92 € to 5,92 € during the past year
What is the PE ratio of Haemato AG?
The price to earnings ratio of Haemato AG is 6,93
What is the cash to sales ratio of Haemato AG?
The cash to sales ratio of Haemato AG is 0,26
What is the registered address of Haemato AG?
The registered address for Haemato AG is Lilienthalstrasse 3a, Schönefeld, Brandenburg, 12529
What is the Haemato AG website address?
The website address for Haemato AG is www.haemato.ag

0VZ7 Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen